TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 46 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $6,522,000 | +0.1% | 6,067,000 | 0.0% | 0.24% | -2.0% |
Q1 2017 | $6,514,000 | -2.3% | 6,067,000 | 0.0% | 0.25% | -0.4% |
Q4 2016 | $6,670,000 | -8.1% | 6,067,000 | -0.3% | 0.25% | -3.1% |
Q3 2016 | $7,254,000 | -10.6% | 6,088,000 | -5.8% | 0.26% | -12.2% |
Q2 2016 | $8,111,000 | -15.6% | 6,460,000 | -12.4% | 0.29% | -6.4% |
Q1 2016 | $9,609,000 | -34.2% | 7,378,000 | -20.7% | 0.31% | -33.8% |
Q4 2015 | $14,598,000 | +3.8% | 9,299,000 | -10.2% | 0.47% | +14.2% |
Q3 2015 | $14,070,000 | -33.0% | 10,357,000 | -31.0% | 0.42% | -22.3% |
Q2 2015 | $20,989,000 | +76.6% | 15,007,000 | +87.6% | 0.53% | +79.2% |
Q1 2015 | $11,884,000 | -20.2% | 8,000,000 | -26.6% | 0.30% | -17.5% |
Q4 2014 | $14,898,000 | +37.8% | 10,894,000 | +29.8% | 0.36% | +31.8% |
Q3 2014 | $10,812,000 | +320.7% | 8,394,000 | +319.7% | 0.27% | +341.9% |
Q2 2014 | $2,570,000 | – | 2,000,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ZAZOVE ASSOCIATES LLC | 83,413,000 | $130,650,000 | 6.13% |
AEGON USA Investment Management, LLC | 6,000,000 | $9,368,000 | 2.35% |
MACKAY SHIELDS LLC | 24,370,000 | $38,152,000 | 2.07% |
INCOME RESEARCH & MANAGEMENT | 4,374,000 | $6,829,000 | 1.11% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 20,000 | $20,347,000 | 0.99% |
SHENKMAN CAPITAL MANAGEMENT INC | 5,269,000 | $8,264,000 | 0.82% |
Mitsubishi UFJ Securities Holdings Co., Ltd. | 325,000 | $511,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 9,299,000 | $14,598,000 | 0.47% |
ADVENT CAPITAL MANAGEMENT /DE/ | 14,543,000 | $23,021,000 | 0.35% |
CSS LLC/IL | 3,750,000 | $5,893,000 | 0.35% |